SEC 13F Intelligence

Trv GP III, LLC / VYGR

Trv GP III, LLC’s Voyager Therapeutics Inc Position

Does Trv GP III, LLC own Voyager Therapeutics Inc (VYGR)? Not currently — the last reported position was 3.19M shares worth $25M in Q1 2023; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$25M
Q1 2023
Shares
3.19M
% of Portfolio
+29.60%
Quarters Held
18
position exited

Position History VYGR

Reported value by quarter
Q4 ’18: $60MQ4 ’18Q1 ’19: $122MQ2 ’19: $174MQ3 ’19: $110MQ3 ’19Q4 ’19: $89MQ1 ’20: $58MQ2 ’20: $81MQ2 ’20Q3 ’20: $68MQ4 ’20: $46MQ1 ’21: $30MQ1 ’21Q2 ’21: $26MQ3 ’21: $17MQ4 ’21: $17MQ4 ’21Q1 ’22: $49MQ2 ’22: $38MQ3 ’22: $32MQ3 ’22Q4 ’22: $33MQ1 ’23: $25Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20233.19M$25M+29.60%
Q4 20225.43M$33M+25.95%
Q3 20225.43M$32M+14.03%
Q2 20226.39M$38M+15.45%
Q1 20226.39M$49M+13.21%
Q4 20216.39M$17M+4.33%
Q3 20216.39M$17M+3.19%
Q2 20216.39M$26M+4.61%
Q1 20216.39M$30M+3.81%
Q4 20206.39M$46M+3.92%
Q3 20206.39M$68M+5.73%
Q2 20206.39M$81M+11.77%
Q1 20206.39M$58M+15.91%
Q4 20196.39M$89M+39.37%
Q3 20196.39M$110M+62.32%
Q2 20196.39M$174M+73.96%
Q1 20196.39M$122M+59.92%
Q4 20186.39M$60M+50.34%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trv GP III, LLC’s full portfolio or all institutional holders of VYGR.